B. Pilmis
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Antibiotic Resistance in Bacteria 30
-
- Antifungal resistance and susceptibility 10
- COVID-19 Clinical Research Studies 9
- Co-authors
- Jean‐Ralph Zahar (33 shared papers)Alban Le Monnier (50 shared papers)Olivier Lortholary (26 shared papers)Assaf Mizrahi (40 shared papers)Fanny Lanternier (10 shared papers)Vincent Jullien (6 shared papers)Caroline Charlier (6 shared papers)Marc Lecuit (6 shared papers)
In The Last Decade
B. Pilmis
129 papers receiving 2.9k citations
B. Pilmis's Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Medicine 363
- Infectious Diseases 920
- Clinical Biochemistry 221
- Applied Microbiology and Biotechnology 99
- Biotechnology 268
Countries citing papers authored by B. Pilmis
This map shows the geographic impact of B. Pilmis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Pilmis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Pilmis more than expected).
Fields of papers citing papers by B. Pilmis
This network shows the impact of papers produced by B. Pilmis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Pilmis. The network helps show where B. Pilmis may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Pilmis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 397 |
| 2 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 3 | 2021 | 258 | |
| 4 | 2017 | 160 | |
| 5 | 2014 | 108 | |
| 6 | 2020 | 90 | |
| 7 | 2015 | 67 | |
| 8 | 2018 | 61 | |
| 9 | 2016 | 56 | |
| 10 | 2017 | 56 | |
| 11 | 2017 | 56 | |
| 12 | 2019 | 53 | |
| 13 | 2017 | 50 | |
| 14 | 2019 | 45 | |
| 15 | 2018 | 42 | |
| 16 | 2019 | 42 | |
| 17 | 2015 | 40 | |
| 18 | 2017 | 38 | |
| 19 | 2020 | 35 | |
| 20 | 2014 | 32 |
About B. Pilmis
B. Pilmis is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Epidemiology and Applied Microbiology and Biotechnology, having authored 142 papers that have together received 3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (30 papers), Bacterial Identification and Susceptibility Testing (14 papers), Antifungal resistance and susceptibility (10 papers), Infective Endocarditis Diagnosis and Management (10 papers), COVID-19 Clinical Research Studies (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Urinary Tract Infections Management (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). The work is most often cited by research in Molecular Medicine (363 citations), Infectious Diseases (920 citations), Clinical Biochemistry (221 citations), Applied Microbiology and Biotechnology (99 citations) and Biotechnology (268 citations). B. Pilmis has collaborated with scholars based in France, Lebanon and Spain. Frequent co-authors include Jean‐Ralph Zahar, Alban Le Monnier, Olivier Lortholary, Assaf Mizrahi, Fanny Lanternier, Vincent Jullien, Caroline Charlier, Marc Lecuit, Gauthier Péan de Ponfilly and Jack D. Sobel. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Journal of Hospital Infection and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.